Related Experiment Video
Updated: May 1, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Bordetella holmesii: an under-recognised Bordetella species
Laure F Pittet1, Stéphane Emonet2, Jacques Schrenzel2
1Department of Paediatrics, Division of General Paediatrics, Children's Hospital, University Hospitals of Geneva, University of Geneva, Geneva, Switzerland.
Abstract:
Bordetella holmesii, first described in 1995, is believed to cause both invasive infections (bacteraemia, meningitis, endocarditis, pericarditis, pneumonia, and arthritis) and pertussis-like symptoms. Infection with B holmesii is frequently misidentified as being with B pertussis, the cause of whooping cough, because routine diagnostic tests for pertussis are not species-specific. In this Review, we summarise knowledge about B holmesii diagnosis and treatment, and assess research needs. Although no fatal cases of B holmesii have been reported, associated invasive infections can cause substantial morbidities, even in previously healthy individuals. Antimicrobial treatment can be problematic because B holmesii's susceptibility to macrolides (used empirically to treat B pertussis) and third-generation cephalosporins (often used to treat invasive infections) is lower than would be expected. B holmesii's adaptation to human beings is continuing, and virulence might increase, causing the need for better diagnostic assays and epidemiological surveillance.
Insights
Bordetella holmesii causes invasive infections and pertussis-like symptoms, often misdiagnosed due to non-specific tests. Research is needed for better diagnosis and treatment strategies against this evolving pathogen.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Bacteriology
Background:
- Bordetella holmesii, identified in 1995, causes invasive infections (bacteraemia, meningitis, pneumonia, etc.) and pertussis-like illness.
- Routine pertussis diagnostics are not species-specific, leading to frequent misidentification of B. holmesii as Bordetella pertussis.
- Invasive B. holmesii infections can lead to significant morbidity, even in healthy individuals.
Purpose of the Study:
- To review current knowledge on Bordetella holmesii diagnosis and treatment.
- To identify research gaps and future needs for managing B. holmesii infections.
- To assess the antimicrobial susceptibility of B. holmesii.
Main Methods:
- Literature review of Bordetella holmesii diagnosis, treatment, and epidemiology.
- Analysis of antimicrobial susceptibility data for B. holmesii.
- Assessment of current diagnostic limitations and surveillance strategies.
Main Results:
- B. holmesii is frequently misdiagnosed as B. pertussis due to non-specific diagnostic tests.
- Antimicrobial susceptibility of B. holmesii to macrolides and cephalosporins is lower than anticipated.
- No fatal cases have been reported, but invasive infections cause considerable morbidity.
Conclusions:
- Improved diagnostic assays are crucial for accurate identification of B. holmesii.
- Antimicrobial treatment strategies may require adjustment due to resistance patterns.
- Enhanced epidemiological surveillance is necessary as B. holmesii continues to adapt and potentially increase in virulence.
Related Concept Videos
Bacterial Phylum Spirochaetes
Other Unique Bacteria
Bacterial Phylum Bacteroidota
Microbiota of the Respiratory Tract
Bacterial Phylum Tenericutes
Regulation of Bacterial Virulence

